Corcept Therapeutics, Inc. (CORT) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Shipping stocks on fire — but cracks are forming in the rate rally
Oppenheimer Downgrades Corcept Therapeutics (CORT) to Perform
November 2, 2012 10:31 AM EDTOppenheimer downgraded Corcept Therapeutics (NASDAQ: CORT) from Outperform to Perform following Q3 results.
For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.
Shares of Corcept Therapeutics closed at $2.24 yesterday, with a 52 week range of $2.23-$4.90.... More
